Research Article
A System Biology-Based Approach for Designing Combination Therapy in Cancer Precision Medicine
Table 9
Quantitative comparison of the results of BD group therapies, where and are therapy agents.
| |||||||||||||||||||||||||||||||||
First column; considered personalize characteristics. Second column; normalized dose value for controlling first characteristic. First row; normalized dose value for controlling 2nd characteristic. |